News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
130,556 Results
Type
Article (5289)
Company Profile (31)
Press Release (125235)
Section
Business (42702)
Career Advice (134)
Deals (7466)
Drug Delivery (10)
Drug Development (15430)
Employer Resources (15)
FDA (2743)
Job Trends (3056)
News (66943)
Policy (4885)
Tag
Academia (309)
Adcomms (3)
Allergies (18)
Alliances (5541)
ALS (19)
Alzheimer's disease (225)
Antibody-drug conjugate (ADC) (59)
Approvals (2811)
Artificial intelligence (44)
Autoimmune disease (6)
Automation (3)
Bankruptcy (44)
Best Places to Work (2756)
Biosimilars (21)
Biotechnology (17)
Bladder cancer (37)
Brain cancer (7)
Breast cancer (102)
Cancer (816)
Cardiovascular disease (66)
Career advice (119)
Career pathing (3)
CAR-T (36)
CDC (3)
Cell therapy (93)
Cervical cancer (9)
Clinical research (13659)
Collaboration (160)
Compensation (68)
Complete response letters (8)
COVID-19 (506)
CRISPR (9)
C-suite (35)
Cystic fibrosis (25)
Data (1090)
Denatured (1)
Depression (19)
Diabetes (63)
Diagnostics (1273)
Digital health (7)
Diversity, equity & inclusion (3)
Drug discovery (16)
Drug pricing (13)
Drug shortages (5)
Duchenne muscular dystrophy (61)
Earnings (33789)
Editorial (9)
Employer branding (3)
Employer resources (13)
Events (23335)
Executive appointments (70)
FDA (3332)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (3)
Funding (130)
Gene editing (20)
Generative AI (3)
Gene therapy (82)
GLP-1 (125)
Government (597)
Grass and pollen (1)
Guidances (238)
Healthcare (3856)
HIV (10)
Huntington's disease (4)
IgA nephropathy (10)
Immunology and inflammation (34)
Immuno-oncology (3)
Indications (10)
Infectious disease (542)
Inflammatory bowel disease (29)
Influenza (10)
Intellectual property (27)
Interviews (22)
IPO (4703)
IRA (2)
Job creations (431)
Job search strategy (101)
Kidney cancer (2)
Labor market (13)
Layoffs (70)
Leadership (1)
Legal (707)
Liver cancer (19)
Longevity (1)
Lung cancer (142)
Lymphoma (69)
Machine learning (3)
Management (5)
Manufacturing (87)
MASH (27)
Medical device (2927)
Medtech (2930)
Mergers & acquisitions (2914)
Metabolic disorders (160)
Multiple sclerosis (27)
NASH (5)
Neurodegenerative disease (26)
Neuropsychiatric disorders (10)
Neuroscience (372)
NextGen: Class of 2025 (1045)
Non-profit (669)
Now hiring (1)
Obesity (68)
Opinion (26)
Ovarian cancer (22)
Pain (17)
Pancreatic cancer (43)
Parkinson's disease (43)
Partnered (4)
Patents (53)
Patient recruitment (36)
Peanut (5)
People (4345)
Pharmaceutical (11)
Pharmacy benefit managers (5)
Phase I (3494)
Phase II (5693)
Phase III (5473)
Pipeline (1118)
Policy (20)
Postmarket research (624)
Preclinical (1192)
Press Release (17)
Prostate cancer (27)
Psychedelics (1)
Radiopharmaceuticals (46)
Rare diseases (101)
Real estate (680)
Recruiting (9)
Regulatory (4135)
Reports (12)
Research institute (301)
Resumes & cover letters (13)
Rett syndrome (5)
RSV (17)
Schizophrenia (18)
Series A (25)
Series B (15)
Sickle cell disease (6)
Special edition (2)
Spinal muscular atrophy (47)
Sponsored (6)
Startups (339)
Stomach cancer (3)
Supply chain (23)
Tariffs (12)
The Weekly (6)
Vaccines (157)
Venture capital (13)
Weight loss (27)
Women's health (3)
Date
Today (22)
Last 7 days (94)
Last 30 days (396)
Last 365 days (7359)
2025 (5639)
2024 (8345)
2023 (9387)
2022 (12147)
2021 (14120)
2020 (12623)
2019 (8297)
2018 (6397)
2017 (5673)
2016 (4921)
2015 (6331)
2014 (4075)
2013 (2930)
2012 (3341)
2011 (3740)
2010 (3290)
Location
Africa (110)
Alabama (15)
Arizona (50)
Arkansas (4)
Asia (7102)
Australia (983)
California (1981)
Canada (802)
China (204)
Colorado (126)
Connecticut (90)
Delaware (59)
Europe (16447)
Florida (303)
Georgia (65)
Idaho (6)
Illinois (129)
Indiana (173)
Japan (77)
Kansas (42)
Kentucky (5)
Louisiana (6)
Maine (41)
Maryland (207)
Massachusetts (1542)
Michigan (51)
Minnesota (86)
Missouri (23)
Montana (5)
Nebraska (3)
Nevada (15)
New Hampshire (15)
New Jersey (849)
New Mexico (5)
New York (522)
North Carolina (297)
Northern California (979)
Ohio (45)
Oregon (3)
Pennsylvania (455)
Puerto Rico (1)
Rhode Island (3)
South America (160)
South Carolina (2)
Southern California (746)
Tennessee (15)
Texas (326)
United States (7633)
Utah (39)
Virginia (19)
Washington D.C. (10)
Washington State (196)
West Virginia (1)
Wisconsin (13)
130,556 Results for "90".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
U.S. Generic Drugs Market Size to Reach USD 196.90 Billion By 2034
October 9, 2025
·
1 min read
Layoffs
BioNTech Cuts 90 Jobs Amid ‘Strategic Alignment’
BioNTech also laid off 63 employees in June in conjunction with the discontinuation of its cell therapy manufacturing operations in Gaithersburg, Maryland.
August 6, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Sirtex Receives Expanded CE Mark Approval for SIR-Spheres® Y-90 Resin Microspheres
September 9, 2025
·
2 min read
IN PARTNERSHIP WITH CRESSET
Why AI Won’t Save the 90% of Clinical Trials That Still Fail
In this episode presented by Cresset, BioSpace’s head of insights Lori Ellis discusses clinical trial fail rates and AI’s potential to reduce preclinical costs with Mutlu Dogruel, VP of AI and Mark Mackey, CSO of Cresset.
August 21, 2025
·
1 min read
·
Lori Ellis
Layoffs
Generation Bio Boots 90% of Staff Amid Dwindling Cash Reserves
The layoffs will not spare Generation’s R&D team, which will initially be retained while the biotech completes its strategic review but will eventually be let go.
August 13, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Onco-Innovations Announces 90% of $0.60 Warrants Have Been Exercised
August 18, 2025
·
2 min read
Press Releases
Citius Oncology Announces Closing of $9.0 Million Registered Direct Offering and Concurrent Private Placement
September 10, 2025
·
7 min read
Press Releases
Citius Oncology Announces Pricing of $9.0 Million Registered Direct Offering and Concurrent Private Placement
September 10, 2025
·
7 min read
Press Releases
Vaxxas secures ~A$90 million in funding to commercialise needle-free vaccination delivery technology
August 25, 2025
·
7 min read
Press Releases
Citius Oncology Announces Closing of $9.0 Million Public Offering
July 18, 2025
·
6 min read
1 of 13,056
Next
